Jb Chemicals & Pharmaceuticals Results Update

Jb Chemicals & Pharmaceuticals Merger & Restructuring

JB Chemicals & Pharmaceuticals' amalgamation with Torrent Pharmaceuticals received NCLT sanction. The scheme will become effective upon filing with the Registrar of Companies.

Jb Chemicals & Pharmaceuticals Management Change

Pradeep Kumar Singh and Suresh Bhise retired from the company. These changes in senior management are effective from June 30, 2026.

Jb Chemicals & Pharmaceuticals Price Movement Clarification

JB Chemicals clarified its audited financial results to the exchange. The board-approved results were signed by a director as authorized.

Jb Chemicals & Pharmaceuticals Management Change

Mr. Bhushan Sachdev resigned as Executive Vice President – Supply Chain Management effective June 12, 2026. Investors should note the departure of a key supply chain executive.

Jb Chemicals & Pharmaceuticals Annual Report

JB Chemicals & Pharmaceuticals Limited filed its Business Responsibility and Sustainability Report for FY 2025-26. The report details company ESG performance, sustainability targets, and governance frameworks.

Jb Chemicals & Pharmaceuticals Annual Report

JB Chemicals & Pharmaceuticals filed its FY26 Business Responsibility and Sustainability Report. The filing highlights its ₹3889.89 Crore turnover and ESG progress for investor review.

Value

₹3,890 Cr

Mukka Proteins Results Update

Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.

Oman facility manufacturing capacity

37200.0 MTPA

Aztec Fluids & Machinery Results Update

Aztec Fluids reported H1 FY27 consolidated revenue of Rs.53.88 crore, up 10.1%, with PAT of Rs.3.58 crore. The release also covers cash flow, balance sheet metrics and the AZTRACE traceability platform.

Ramky Infrastructure Results Update

Ramky Infrastructure's press release reports Q2 FY27 consolidated revenue up 28% and PAT up 36%. Half-year consolidated PAT fell 7%, while standalone PAT rose 21%.

Striders Impex Results Update

Striders Impex's H1 FY27 revenue rose 50.5% to ₹39.2 crore, yet EBITDA fell 35.9% to ₹1.6 crore. Profit after tax dropped to ₹0.8 crore on higher costs.

Jaro Institute of Technology Management and Research Results Update

Jaro Education's press release reports H1 FY27 PAT up 21% and Total Income up 15%. New academic and corporate partnerships were also announced.

Tata Chemicals Results Update

Tata Chemicals' Q2FY27 standalone revenue rose 8% to ₹1,303 Cr, with EBITDA up 22%. Consolidated results show a ₹50 Cr loss after tax amid soda ash pricing pressure.